Duearity AB (OSTO:DEAR) EBIT: kr-32.16 Mil (TTM As of Jun. 2024)


What is Duearity AB EBIT?

Duearity AB OSTO:DEAR EBIT is kr-32.16 Mil as of Jun. 2024.

Duearity AB's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2024 was kr-4.73 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was kr-32.16 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Duearity AB's annualized ROC % for the quarter that ended in Jun. 2024 was -135.04%. Duearity AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -510.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Duearity AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -440.12%.


Duearity AB  (OSTO:DEAR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Duearity AB's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-18.924 * ( 1 - 0% )/( (13.207 + 14.821)/ 2 )
=-18.924/14.014
=-135.04 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Duearity AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-18.92/( ( (3.721 + max(-8.25, 0)) + (3.688 + max(-12.042, 0)) )/ 2 )
=-18.92/( ( 3.721 + 3.688 )/ 2 )
=-18.92/3.7045
=-510.73 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.663 + 4.134 + 0.00099999999999945) - (5.204 + 0 + 7.844)
=-8.25

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.533 + 5.346 + 0.0010000000000003) - (8.431 + 0 + 9.491)
=-12.042

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Duearity AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-32.155/7.306
=-440.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Duearity AB EBIT Related Terms


Duearity AB EBIT Historical Data

* Premium members only.

The historical data trend for Duearity AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Duearity AB EBIT Chart

Duearity AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EBIT
-1.33 -15.36 -19.16 -25.72

Duearity AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.23 -7.86 -13.03 -6.53 -4.73

OSTO:DEAR vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Duearity AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Duearity AB EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Duearity AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Duearity AB's EV-to-EBIT falls into.



Duearity AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-32.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of kr-32.16 Mil mean?
Duearity AB (OSTO:DEAR) has a EBIT of kr-32.16 Mil as of Jun. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Duearity AB.
Is Duearity AB's EBIT too high?
Duearity AB's current EBIT is kr-32.16 Mil.
How does Duearity AB's EBIT compare to ABT and SYK?
Duearity AB's EBIT of kr-32.16 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Duearity AB. Duearity AB's current EBIT is kr-32.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Duearity AB stock overvalued right now?
Duearity AB (OSTO:DEAR) has a current EBIT of kr-32.16 Mil. The current EBIT is kr-32.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Duearity AB (OSTO:DEAR), the current EBIT is kr-32.16 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Duearity AB Business Description

Address Krusegrand 42D, Malmo, SWE, 212 25
Duearity AB is a medical technology company. It develops smallest and flexible products and services for tinnitus under the Tinearity brand.